Can l-carnitine reduce post-COVID-19 fatigue?

A significant number of patients infected with the new coronavirus suffer from chronic fatigue syndrome after COVID-19, and their symptoms may persist for months after the infection. Nevertheless, no particular treatment for post-disease fatigue has been found. At the same time, many clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaziri-harami, Roya, Delkash, Parisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667465/
https://www.ncbi.nlm.nih.gov/pubmed/34925826
http://dx.doi.org/10.1016/j.amsu.2021.103145
_version_ 1784614392012210176
author Vaziri-harami, Roya
Delkash, Parisa
author_facet Vaziri-harami, Roya
Delkash, Parisa
author_sort Vaziri-harami, Roya
collection PubMed
description A significant number of patients infected with the new coronavirus suffer from chronic fatigue syndrome after COVID-19, and their symptoms may persist for months after the infection. Nevertheless, no particular treatment for post-disease fatigue has been found. At the same time, many clinical trials have shown the effectiveness of l-carnitine in relieving fatigue caused by the treatment of diseases such as cancer, MS, and many other diseases. Therefore, it can be considered as a potential option to eliminate the effects of fatigue caused by COVID-19, and its consumption is recommended in future clinical trials to evaluate its effectiveness and safety.
format Online
Article
Text
id pubmed-8667465
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86674652021-12-14 Can l-carnitine reduce post-COVID-19 fatigue? Vaziri-harami, Roya Delkash, Parisa Ann Med Surg (Lond) Review A significant number of patients infected with the new coronavirus suffer from chronic fatigue syndrome after COVID-19, and their symptoms may persist for months after the infection. Nevertheless, no particular treatment for post-disease fatigue has been found. At the same time, many clinical trials have shown the effectiveness of l-carnitine in relieving fatigue caused by the treatment of diseases such as cancer, MS, and many other diseases. Therefore, it can be considered as a potential option to eliminate the effects of fatigue caused by COVID-19, and its consumption is recommended in future clinical trials to evaluate its effectiveness and safety. Elsevier 2021-12-13 /pmc/articles/PMC8667465/ /pubmed/34925826 http://dx.doi.org/10.1016/j.amsu.2021.103145 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Vaziri-harami, Roya
Delkash, Parisa
Can l-carnitine reduce post-COVID-19 fatigue?
title Can l-carnitine reduce post-COVID-19 fatigue?
title_full Can l-carnitine reduce post-COVID-19 fatigue?
title_fullStr Can l-carnitine reduce post-COVID-19 fatigue?
title_full_unstemmed Can l-carnitine reduce post-COVID-19 fatigue?
title_short Can l-carnitine reduce post-COVID-19 fatigue?
title_sort can l-carnitine reduce post-covid-19 fatigue?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667465/
https://www.ncbi.nlm.nih.gov/pubmed/34925826
http://dx.doi.org/10.1016/j.amsu.2021.103145
work_keys_str_mv AT vaziriharamiroya canlcarnitinereducepostcovid19fatigue
AT delkashparisa canlcarnitinereducepostcovid19fatigue

Ejemplares similares